Skip to main content
Top

Journal of Endocrinological Investigation

Issue 3/1999

Content (15 Articles)

Original Article

The pituitary uptake of 111In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas

A. Colao, S. Lastoria, D. Ferone, P. Varrella, P. Marzullo, R. Pivonello, G. Cerbone, W. Acampa, M. Salvatore, G. Lombardi

Original Article

Are thyroid function tests too frequently and inappropriately requested?

E. Roti, E. Gardini, M. G. Magotti, S. Pilla, R. Minelli, M. Salvi, C. Monica, D. Maestri, S. Cencetti, L. E. Braverman

Original Article

Coexistence of primary hyperparathyroidism and thyroid disease

M. Regal, C. Páramo, R. Luna Cano, L. F. Pérez Méndez, J. M. Sierra, I. Rodríguez, R. V. García-Mayor

Original Article

Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays

B. Cavaco, S. Prazeres, M. A. Santos, L. G. Sobrinho, V. Leite

Case Report

Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis

G. Babini, L. Gurioli, R. Rizzi, P. Bertello

Case Report

Reversible cerebral ischemia in patients with pheochromocytoma

F. S. Lehmann, P. Weiss, R. Ritz, F. Harder, J. -J. Staub

Opinions

Is thyroxine during lithium therapy necessary?

L. Bartalena, F. Bogazzi, E. Martino

Endocrinology and Art

“The Tooth Drawer”

Enio Martino

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.